Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXRN8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,808
Award facts
- Contract value 100% obligated
- $21,807.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,807.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on a firm fixed price basis. This non-competitive delivery order, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this order—is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Zepbound, a diabetes treatment medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract mechanisms that ensure rapid fulfillment of essential pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26FXRN8?
SPE2DR26FXRN8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FXRN8 worth?
The government has obligated $21,808 on SPE2DR26FXRN8.
Is contract SPE2DR26FXRN8 an order under another contract?
Yes. SPE2DR26FXRN8 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXRN8 competed?
The extent of competition for SPE2DR26FXRN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award